"ABL Diagnostics Signs Share Purchase and Loan Agreement with Alumni Capital for Strategic Collaboration"

"ABL Diagnostics, a Paris-based molecular biology diagnostics company, has entered into a share purchase and loan agreement with Alumni Capital, an alternative investment fund specializing in small-cap companies globally. The agreement involves successive sales of ABL Diagnostics shares and a share loan mechanism over 24 months. Legal counsel for Alumni Capital was provided by CMS Francis Lefebvre, while ABL SA was advised by ATOZ."

CMS Francis Lefebvre advised Alumni Capital, while ATOZ assisted Advanced Biological Laboratories SA (ABL SA) in the transaction. The transaction involved a share purchase and share loan agreement between ABL SA and Alumni Capital. ABL SA, the parent company of ABL Diagnostics, an international company listed on the regulated market of Euronext in Paris specializing in innovative molecular biology tests, agreed to sell existing shares of ABL Diagnostics to Alumni Capital in successive transactions initiated by ABL SA. The agreement also included a share loan mechanism and has a duration of 24 months. This follows a prior transaction announced in August 2025, where ABL SA sold a block of shares of ABL Diagnostics to Alumni Capital. The CMS Francis Lefebvre team advising Alumni Capital consisted of Bertrand Sénéchal, partner, and Victor Delion, associate.

"ABL Diagnostics Signs Share Purchase and Loan Agreement with Alumni Capital for Strategic Collaboration"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads